Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05185531 |
|---|---|
| Brief Title: | A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma (Notable-HCC) |
| First Submitted : | December 19, 2021 |
| First Submitted that Met QC Criteria : | January 5, 2022 |
| First Posted : | January 11, 2022 |
| Last Update Submitted that Met QC Criteria : | November 16, 2022 |
| Last Update Posted : | November 21, 2022 |